Home > Healthcare > Medical Devices > Diagnostic Devices > Neuroendoscopy Market

Neuroendoscopy Market Trends

Report ID: GMI4039
Published Date: May 2023
Report Format: PDF

Download Free Sample

Neuroendoscopy Market Trends

Recent technological advancements and developments in manufacturing of novel neuroendoscopy devices will boost the market growth in the near future. Several novel neuroendoscopy devices and new technologies have significantly impacted the neuroendoscopy industry growth owing to enhancement in fiber optics and imaging, and innovation in new surgical approaches. Continuous upgradation of technology allows introduction of numerous types of technologically intensive neuroendoscopes that assist neurosurgeons in conducting complicated brain and central nervous system related surgeries. Development of such neuroendoscopes has resulted in growing convenience and ease of performing surgical procedures accelerating the business growth across the globe.

Authors: Mariam Faizullabhoy

Frequently Asked Questions (FAQ) :

Global market size for neuroendoscopy was worth around USD 142.7 million in 2022 and is projected to reach over USD 241.3 million by 2032 attributed to the high prevalence of neurological disorders and technological innovations in neuroendoscopy devices.

The rigid neuroendoscopes segment held more than 66% market share in 2022 and is poised to gain significant traction through 2032 as these products offer more durability and are suitable for repeated use and sterilization.

U.S. market for neuroendoscopy is estimated to reach USD 80.1 million by the end of 2032 attributable to the presence of key market players and the rising awareness regarding the benefits offered by neuroendoscopy for diagnosis and treatment.

Ackermann Instrumente GmbH, Adeor Medical AG, Advanced Biologics, AdvinHealthcare, B. Braun Melsungen AG, Chongqing Xishan Science & Technology Co., Ltd., Clarus Medical LLC, KARL STORZ, Machida Endoscope Co., Ltd. and Schindlerendoskopie technologie GmbH are some of the major companies in the neuroendoscopy business.